The University of Pennsylvania (Penn) operates in a major healthcare and life sciences cluster in Philadelphia. It ranks as the fourth most innovative university in the world and its 189 research centers and institutes push the boundaries in life science fields. The...
TrialSite News a while back surveyed stem cell clinics across America. Titled ‘Stem Cell Research: Promise and Possible Peril,’ we showcased how quacks are running amok in America and the Caribbean, putting patients’ lives in danger not to mention swindling them...
A Ukrainian national football hero and trainer of the national team, Andriy Shevchenko, will participate in an upcoming Institute for Cell Therapy-sponsored event discussing stem cell therapy-based clinical trial results in the Ukraine. In partnership with the...
Mount Sinai Medical Center, internationally acclaimed for its excellence in research, patient care, education in multiple sclerosis and a range of medical specialties, was recruited by clinical sponsor BrainStorm Cell Therapeutics, Inc (BCLI) as a clinical trial site...
The value-driven, precision-based drug development boom now underway introduces new complexity and competitive dynamics for drug development including clinical trials. Traditional small molecule-based biotech therapies focus on addressing symptoms of disease while...
Recently IQVIA’s Erin Finot’s recently discussed the importance of site selection for clinical trials involving advanced therapies (ATs). Represented by gene and cell therapies, this movement pushes the scientific and technological envelope in the quest to improve...
